Small Cap Feast

11th July 2024

Dish of the day
No Joiners today
Off the menu
No leavers today

Dish Of The Day:


Rosebank Industries (ROSE.L) has joined the AIM Market today. The Company's market capitalisation (at the Placing Price of 250p) is £50m. Net proceeds of the issue are £49m. Rosebank is a newly incorporated company established to acquire businesses whose performance the Directors believe can be improved so as to create shareholder value. The Rosebank Co-Founders were previously members of the senior management team of Melrose, a FTSE100 company which is listed on the London Stock Exchange.



What's baking in the oven?

Potential**** Initial Public Offerings:

ITF announced:

8th July 2024: Rome Resources: The Canada-based early-stage resource exploration Company has announced its intention to IPO on AIM in order to continue to make financial progress on its “Bisie North Tin Project”. The Company’s first day of trading on AIM is expected to be 26th July 2024. The Primary Offer expected size is approximately £4.0m.

24th June 2024: Rosebank Industries: The Company aims to repeat the successful 'Buy, Improve, Sell' business model which the Rosebank Co-Founders implemented during their time at Melrose. Rosebank proposes to acquire quality industrial or manufacturing businesses whose performance may be improved. The Company’s first day of trading on AIM is expected to be 11th July 2024. The primary offer expected size is approximately £50m.

Banquet Buffet

Cambridge Cognition Holdings  39.50p £16.48m (COG.L)

The digital technology solutions provider delivering more effective brain health assessments announces that it has secured a grant from Innovate UK for the Bio-Hermes 2 project.  The Company has been selected to provide voice and touchscreen cognitive assessments that will contribute to generating a world-leading dataset to improve the understanding of how digital and blood-based biomarkers can be used to predict the extent of Alzheimer’s Disease pathology. Matthew Stork, Chief Executive Officer of Cambridge Cognition, has commented that the Board is grateful to Innovate Uk for the funding and believe this could be a groundbreaking study, particularly for the clinical field.

Cornish Metals Inc. 5.70 £30.51m (CUSN.L)

The dual-listed mineral exploration and development company focused on advancing the South Crofty high-grade (an underground tin project in Cornwall) has commenced the second phase of the shaft refurbishment at the project. The Refurbishment of New Cook's Kitchen shaft is progressing as planned with the on-schedule installation of the Phase 2 work platform, whilst mine dewatering continues with the submersible pumps operating at a rate of approximately 300 cubic metres per hour. The Company believes this is an important milestone to continue to make operational and corporate progress in the industrial mining industry.

Domino’s Pizza Poland 11.00p £98.86m (DPP.L)

DP Poland, the operator of corporately managed and sub-franchised Domino’s pizza delivery stores across Poland and Croatia, has issued a trading update for the six months to 30 June 2024. It reported strong commercial progress with a third consecutive year of growth in excess of 15% in the first half and Poland’s LFL System Sales increased by 22.2%, driven by rising System Orders in Poland of 19%. Croatia experienced similar success as total system sales growth reached 68.6% and operationally the Company’s store numbers remain on track to open 16 locations and meet market expectations for 2024.

Ilika 28.00p £43.50m (IKA.L)

The solid-state battery technology supplier for the Industrial IoT and MedTech markets has published full year results for the year ended 30 April 2024. During the Period, Ilika continued to develop and commercialise its thin-film Stereax solid state batteries and large-format Goliath cells for electric vehicles. Significantly, the Company achieved a turnover of £2.1m (300% increase from the previous year) and strengthened its liquidity position with cash, cash equivalents and longer term bank deposits of £11.9m. A further  £2.3m was successfully fundraised to support the Goliath roadmap and Stereax commercialisation. Graeme Purdy, Ilika's Chief Executive Officer, is pleased with the operational progress made and will aim to capitalise on any opportunities in the UK EV battery market (estimated to be worth £9bn by 2030).

Jade Road Investments Limited 1.38p £4.89m (JADE.L)*

AIM listed finance provider that focuses on income-production by seeking the best risk-adjusted returns has announced key management changes. Dr. Lee George Lam has decided to resign with immediate effect from his position as non-executive director of the Company, with John Croft (Executive Chairman) thanking Dr. Lam for his significant contribution to the Company over many years .

MediaZest (MDZ.L) 0.0775p £1.3m *

The creative audio-visual solutions provider announced that the Company’s latest Investor Meet Company presentation and Q&A with CEO, Geoff Robertson is now available to replay on the MediaZest website. The presentation provides an overview of the Company and MediaZest’s unaudited interim results for the six months ended 31 March 2024, which showed considerable improvement on the prior comparative period, with the business growing revenue and reducing losses.

Onward Opportunities Limited 122.50p £24.70m (ONWD.L)

Onward Opportunities is an investment company targeting the small UK business sector through strong industry experience and today provided a half-year update for the six-month period ended 30 June 2024, ahead of the publication of its unaudited HY24 interim results in September 2024. The financial performance was above expectations with net asset value per share reaching 116.32p, equating to a total return of +9.2% over the six-month period, whilst completing two additional capital raises during the period, totalling £4.7m, increasing Onward Opportunities' capital base by 25%. Laurence Hulse, Lead Fund Manager, was delighted with the NAV return progress and is looking forward to the portfolio developing further with the additional funds raised this year.

Savannah Resources 4.05p £88.00m (SAV.L)

The mineral resource development company focusing on the industrial metals and mining sector has detailed further results from the first phase of the current two stage Definitive Feasibility Study (DFS)  drilling programme at the Barroso Lithium Project in Northern Portugal.  Savannah reports significant lithium assays which it has received from a further 8 diamond drill holes and crucially at Pinheiro, the results from metallurgical and resource diamond drilling have confirmed the tenure of lithium mineralisation highlighting the potential for expansion of the resource.  Planning is currently underway for Phase 2 of the DFS drilling programme.

Springfield Properties 96.50p £115.70m (SPR.L)

A leading housebuilder in Scotland focused on delivering private and affordable housing, provide a trading update for the year ended 31 May 2024. Despite challenging market conditions subduing homebuyer confidence and reducing affordable housing activity, the Group reports falling bank debts to £40m at 31 May 2024, ahead of stated target of £55.0m, and profit before tax above market expectations due to good profits being made from land sales of £28m during the period. Expected revenues are slightly lower than the previous year at £266m, but overall Springfield Properties is on track to meet market expectations for FY 2025.

Totally 7.90p £14.25m (TLY.L)

AIM listed provider of  frontline healthcare, corporate fitness, and wellbeing services, mainly to the NHS, announces a total of six post-election contract extensions worth around £11m.  Three care contracts, valued at c.£8m help to reduce elective care waiting lists for an expanded range of specialities including Gastroenterology, Gynaecology and Ophthalmology. Three other contract extensions support urgent care services worth £3.5m and include the delivery of GP Out of Hours services and Clinical Assessment.  May’s Trading update for the March 2024 year end, which are due to be reported shortly, illustrate the challenges of fixed cost contracts, intensive cost pressures and meeting ‘high’ service delivery standards.  Totally has seen a 22% year on year reduction in revenue to £106m, but EBITDA has improved from £1.1m to £2.2m.  With gross cash at around £2.3m, the Company is on the verge of being cash flow positive. We also note Stonehage Fleming Investment Management has accrued a 14% holding.


11 July 2024
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced, or it is a rumour


Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram